Multiple Sclerosis
The AJMC® Multiple Sclerosis compendium is a comprehensive resource for clinical news and expert insights for the disabling disease that impacts the brain and spinal cord.
Latest News
Examining the Role of a Novel Class of Medications for the Management of Multiple Sclerosis
This video series provides an in-depth look at multiple sclerosis, covering its impact, pathophysiology, treatment strategies, unmet needs, patient satisfaction, and future research. Gain key insights into managing and understanding this condition.
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Multiple Sclerosis: Looking Toward the Future
Primary Progressive Multiple Sclerosis Treatment Landscape: Emerging Therapies
Updates in Recent Clinical Trials in the Treatment of Multiple Sclerosis
BTK Inhibitors' Rationale and Potential Role in Multiple Sclerosis Treatment
Typical Payer Coverage Criteria for Multiple Sclerosis Therapies
Examining Challenges with Drug Switching and Step Therapy in MS Treatment
Incorporating a Subcutaneous Novel Therapy into Multiple Sclerosis Treatment
MS Treatment Guidelines: Expert Insights on Updates and Decision-Making
Dr Ari Green on Promising Remyelination Therapies and Patient Outcomes in MS
Dr Mitzi Joi Williams Discusses Clinical Trial Accessibility Challenges, Solutions
Millennials With Multiple Sclerosis: Are They Different or Has Medicine Evolved?
Podcast: This Week in Managed Care—Challenges of Rural Healthcare Delivery and Other Health News
Podcast: This Week in Managed Care—Opioid Ruling and Settlement, and Other Health News
Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care
Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment
The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
More News
Achieving the Goals of Value-Based Care for Multiple Sclerosis
